it took Illumina five years to develop its latest sequencing platform, the NovaSeq X, which we use as a barometer for how long it could take for a competitor to engineer a similar product.

China announced a ban on Tuesday on imports of genetic sequencers from U.S. medical equipment maker Illumina, just minutes ...

Illumina has established a strong foothold in the market. The company’s product portfolio includes high-throughput sequencers like the NovaSeq X series, as well as lower-throughput instruments ...